NovaBay Pharmaceuticals Inc. (NBY)
$1.64
$0.00 (0.00%)As on 15-May-2026 09:30EDT
Market cap
$52 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
--
P/B Ratio
1.5
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-1 Mln
-
ROE
-5.2 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
-0.3
-
Debt to Equity
0
-
Book Value
$-0.9
-
EPS
$16.6
-
Face value
--
-
Shares outstanding
26,625,029
10 Years Aggregate
CFO
$-90.40 Mln
EBITDA
$-100.48 Mln
Net Profit
$-115.26 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
NovaBay Pharmaceuticals (NBY)
| -94.2 | -1.2 | -36.9 | -44.9 | -78.7 | -79.0 | -60.1 |
|
BSE Sensex
| -11.1 | -2.1 | -8.9 | -7.5 | 6.6 | 9.1 | 11.4 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
NovaBay Pharmaceuticals (NBY)
| 838.4 | -91.2 | -89.7 | -85.3 | -45.5 | 8.9 | -17.2 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
NovaBay Pharmaceuticals (NBY)
|
1.6 | 51.9 | 0.0 | 522.6 | -- | 744.1 | -- | 1.5 |
| 76.7 | 10,950.2 | 622.0 | -300.9 | -7.4 | -62.9 | -- | 16.7 | |
| 240.5 | 14,745.0 | 867.5 | 506.6 | -2.8 | -- | 26.7 | 25.7 | |
| 75.9 | 10,123.1 | 105.8 | -829.6 | -718.2 | -- | -- | 60.3 | |
| 50.1 | 12,494.9 | 2,375.5 | 833.4 | 40.8 | 40.7 | 16.5 | 6.3 | |
| 94.9 | 12,823.7 | 1,080.2 | -433.2 | -29.6 | -- | -- | 55.7 | |
| 306.3 | 9,223.6 | 417.3 | 225.0 | 42.8 | 18.6 | 41.8 | 7.1 | |
| 523.7 | 11,459.4 | 1,132.5 | -309.4 | -25.5 | -52.9 | -- | 21.6 | |
| 415.3 | 11,917.7 | 2,678.3 | 460.4 | 21.1 | 103.2 | 26.2 | 20.2 | |
| 342.6 | 9,250.5 | 0.0 | -326.5 | -- | -37.2 | -- | 6.5 |
Shareholding Pattern
View DetailsAbout NovaBay Pharmaceuticals (NBY)
NovaBay Pharmaceuticals, Inc. engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky... Protocol. Its services intend to support protocol-level services, including staking, governance participation, validation, and related activities. The company was formerly known as NovaCal Pharmaceuticals, Inc. and changed its name to NovaBay Pharmaceuticals, Inc. in February 2007. NovaBay Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Emeryville, California. Read more
-
President, CEO, General Counsel, Chief Compliance Officer, Corporate Secretary & Director
Mr. Justin M. Hall Esq.
-
President, CEO, General Counsel, Chief Compliance Officer, Corporate Secretary & Director
Mr. Justin M. Hall Esq., J.D.
-
Headquarters
Emeryville, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for NovaBay Pharmaceuticals (NBY)
What is the current share price of NovaBay Pharmaceuticals Inc (NBY) Today?
The share price of NovaBay Pharmaceuticals Inc (NBY) is $1.64 (NYSE) as of 15-May-2026 09:30 EDT. NovaBay Pharmaceuticals Inc (NBY) has given a return of -78.7% in the last 3 years.
What is the current PB & PE ratio of NovaBay Pharmaceuticals Inc (NBY)?
Since, TTM earnings of NovaBay Pharmaceuticals Inc (NBY) is negative, P/E ratio is not available.
The P/B ratio of NovaBay Pharmaceuticals Inc (NBY) is 1.53 times as on 15-May-2026, a 66 discount to its peers’ median range of 4.49 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-1.48
|
-1.44
|
|
2024
|
-0.41
|
-22.76
|
|
2023
|
-0.02
|
0.06
|
|
2022
|
-0.35
|
0.35
|
|
2021
|
-0.01
|
0.01
|
What is the 52 Week High and Low of NovaBay Pharmaceuticals Inc (NBY)?
The 52-week high and low of NovaBay Pharmaceuticals Inc (NBY) are Rs 99.75 and Rs 1.11 as of 17-May-2026.
What is the market cap of NovaBay Pharmaceuticals Inc (NBY)?
NovaBay Pharmaceuticals Inc (NBY) has a market capitalisation of $ 52 Mln as on 15-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in NovaBay Pharmaceuticals Inc (NBY)?
Before investing in NovaBay Pharmaceuticals Inc (NBY), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.